Stephen Haworth
Chief Tech/Sci/R&D Officer at XORTX THERAPEUTICS INC.
Net worth: - $ as of 29/04/2024
Stephen Haworth active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 30/06/2021 | - |
Career history of Stephen Haworth
Former positions of Stephen Haworth
| Companies | Position | Start | End |
|---|---|---|---|
| CORMEDIX INC. | Chief Tech/Sci/R&D Officer | 31/12/2016 | 31/12/2017 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Chief Tech/Sci/R&D Officer | 29/02/2012 | 31/03/2013 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 31/03/2015 | 31/03/2016 |
Training of Stephen Haworth
| UCL Medical School | Doctorate Degree |
| University College London | Undergraduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 3 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| Private companies | 2 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
- Stock Market
- Insiders
- Stephen Haworth
- Experience
